Covaxin from Bharat Biotech gets emergency approval for kids aged 2 to 18
Bharat Biotech’s Covaxin has been given emergency use approval by the Covid-19 Subject Expert Committee for children aged 2 to
Read MoreBharat Biotech’s Covaxin has been given emergency use approval by the Covid-19 Subject Expert Committee for children aged 2 to
Read MoreThough the meeting will not be a detailed review of the product, the vaccine maker will have an opportunity to
Read MoreAnother delighted news, Researchers at ICMR-NIV collected sera from 20 recovered patients and 17 people who had received the Covaxin
Read More